Biogen Inc/ US09062X1037 /
| 2024-04-26 10:00:00 PM | Chg. +6.4400 | Volume | Bid1:47:07 AM | Ask1:47:07 AM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 208.9000USD | +3.18% | 1.89 mill. Turnover: 240.5 mill. |
208.5000Bid Size: 100 | 209.0000Ask Size: 200 | 30.42 bill.USD | - | 26.05 |
Assets
| 2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 3,601.2000 | 3,247.3000 | 3,411.5000 | 3,416.4000 | 3,298.6000 | ||||||
| Intangible Assets | 3,120 | 3,527.4000 | 3,084.3000 | 2,221.3000 | 1,850.1000 | ||||||
| Long-Term Investments | 1,375.9000 | 1,408.1000 | 772.1000 | 892 | 705.7000 | ||||||
| Fixed Assets | 17,648 | 18,852.5000 | 17,731.8000 | 16,020.8000 | 14,762.9000 | ||||||
| Inventories | 929.9000 | 804.2000 | 1,068.6000 | 1,351.5000 | 1,344.4000 | ||||||
| Accounts Receivable | 1,958.5000 | 1,880.5000 | 1,913.8000 | 1,549.4000 | 1,705 | ||||||
| Cash and Cash Equivalents | 1,224.6000 | 2,913.7000 | 1,331.2000 | 2,261.4000 | 3,419.3000 | ||||||
| Current Assets | 7,640.9000 | 8,381.8000 | 6,887.1000 | 7,856.5000 | 9,791.2000 | ||||||
| Total Assets | 25,288.9000 | 27,234.3000 | 24,618.9000 | 23,877.3000 | 24,554.1000 | ||||||
Liabilities
| 2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 370.5000 | 530.8000 | 454.9000 | 589.2000 | 491.5000 | ||||||
| Long-term debt | 5,936.5000 | 4,459 | 7,426.2000 | 6,274 | 6,281 | ||||||
| Liabilities to Banks | 5,936.5000 | 4,459 | 7,426.2000 | 6,274 | - | ||||||
| Provisions | 1,699.7000 | 2,882.2000 | 1,174.8000 | 869.2000 | - | ||||||
| Liabilities | 12,257.3000 | 13,895.2000 | 13,932.8000 | 12,917.6000 | 11,165.7000 | ||||||
| Share Capital | .1000 | .1000 | .1000 | .1000 | .1000 | ||||||
| Total Equity | 13,031.6000 | 13,339.1000 | 10,686.1000 | 10,959.7000 | 13,388.4000 | ||||||
| Minority Interests | -8 | -4.1000 | -14.2000 | 63.5000 | -9.5000 | ||||||
| Total liabilities equity | 25,288.9000 | 27,234.3000 | 24,618.9000 | 23,877.3000 | 24,554.1000 | ||||||
Income Statement
| 2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 13,452.9000 | 14,377.9000 | 13,444.6000 | 10,981.7000 | 10,173.4000 | ||||||
| Depreciation (total) | 1,016.6000 | 680.6000 | 457.2000 | 487.7000 | 518.4000 | ||||||
| Operating Result | 5,888.6000 | 7,042.6000 | 4,550.1000 | 2,840.7000 | - | ||||||
| Interest Income | -88.1000 | -67.4000 | -180.5000 | -242.6000 | -157.3000 | ||||||
| Income Before Taxes | 5,899.6000 | 7,125.9000 | 5,047.5000 | 1,745.2000 | 3,591.8000 | ||||||
| Income Taxes | 1,425.6000 | 1,158 | 992.3000 | 52.5000 | 632.8000 | ||||||
| Minority Interests Profit | 43.3000 | 0.0000 | 59.9000 | 171.5000 | -85.3000 | ||||||
| Net Income | 4,430.7000 | 5,888.5000 | 4,000.6000 | 1,556.1000 | 3,046.9000 | ||||||
Per Share
Cash Flow
| 2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 6,187.7000 | 7,078.6000 | 4,229.8000 | 3,639.9000 | 1,384.3000 | ||||||
| Cash Flow from Investing Activities | -2,046.3000 | 470.5000 | -608.6000 | -563.7000 | 1,576.6000 | ||||||
| Cash Flow from Financing | -4,472 | -5,860.4000 | -5,272.7000 | -2,086.2000 | -1,747.3000 | ||||||
| Decrease / Increase in Cash | -330.6000 | 1,688.7000 | -1,651.5000 | 990 | 1,213.6000 | ||||||
| Employees | 7,800 | 7,400 | 9,100 | 9,610 | - | ||||||
